Ping Mao
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Genetics top 2%
- Glioma Diagnosis and Treatment
Papers in ⓘ
-
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 10
- Genetics 12
- Glioma Diagnosis and Treatment 9
- Co-authors
- Maode Wang (9 shared papers)Kaushal Joshi (3 shared papers)Robert W. Sobol (3 shared papers)L.T. Smith (2 shared papers)Soumya Luthra (2 shared papers)Bo Hu (2 shared papers)Sung-Hak Kim (2 shared papers)Lucas Santana‐Santos (2 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Cell Cycle (3 papers)Acta Pharmaceutica Sinica B (2 papers)The Analyst (2 papers)Plant Diversity (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ping Mao
117 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Cancer Research 582
- Genetics 377
- Molecular Biology 1.2k
- Oncology 408
- Geriatrics and Gerontology 44
Countries citing papers authored by Ping Mao
This map shows the geographic impact of Ping Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Mao more than expected).
Fields of papers citing papers by Ping Mao
This network shows the impact of papers produced by Ping Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Mao. The network helps show where Ping Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3 Hit paper breakdown → | 2013 | 501 |
| 2 | 2013 | 165 | |
| 3 | Emerging ELISA derived technologies for in vitro diagnostics Hit paper breakdown → | 2022 | 157 |
| 4 | 2015 | 84 | |
| 5 | 2012 | 79 | |
| 6 | Type and dose-response effect of adverse childhood experiences in predicting depression: A systematic review and meta-analysis Hit paper breakdown → | 2023 | 56 |
| 7 | 2016 | 50 | |
| 8 | 2016 | 46 | |
| 9 | 2012 | 45 | |
| 10 | 2017 | 42 | |
| 11 | 2021 | 41 | |
| 12 | 2020 | 38 | |
| 13 | 2018 | 36 | |
| 14 | 2022 | 35 | |
| 15 | 2012 | 34 | |
| 16 | 2015 | 31 | |
| 17 | 2013 | 30 | |
| 18 | 2016 | 30 | |
| 19 | 2022 | 30 | |
| 20 | 2015 | 28 |
About Ping Mao
Ping Mao is a scholar working on Cancer Research, Genetics, Hematology, Leadership and Management and Molecular Biology, having authored 124 papers that have together received 2.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (10 papers), Glioma Diagnosis and Treatment (9 papers), Circular RNAs in diseases (8 papers), Hematopoietic Stem Cell Transplantation (7 papers), Child and Adolescent Psychosocial and Emotional Development (7 papers), Cancer Mechanisms and Therapy (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (582 citations), Genetics (377 citations), Molecular Biology (1.2k citations), Oncology (408 citations) and Geriatrics and Gerontology (44 citations). Ping Mao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Maode Wang, Kaushal Joshi, Robert W. Sobol, L.T. Smith, Soumya Luthra, Bo Hu, Sung-Hak Kim, Lucas Santana‐Santos, Panayiotis V. Benos and Ichiro Nakano. Their work appears in journals such as Biomedicine & Pharmacotherapy, Cell Cycle, Acta Pharmaceutica Sinica B, The Analyst and Plant Diversity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.